Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis

Published:2022-04 Issue:4 Volume:46 Page:101816
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Fatima Kaneez,Moeed Abdul^ORCID,Waqar Eisha,Atif Abdul Raafe^ORCID,Kamran Alishba^ORCID,Rizvi Hura,Suri Noor Fatima^ORCID,Haider Hoorain,Shuja Syed Hasan^ORCID,Khalid Mariam^ORCID,Minhas Abdul Mannan Khan

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030;Estes;J Hepatol,2018

3. Complications, morbidity and mortality of nonalcoholic fatty liver disease;Mantovani;Metabolism,2020

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

5. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin Use and Development and Progression of Nonalcoholic Fatty Liver Disease Based on Ultrasonography;The Journal of Clinical Endocrinology & Metabolism;2024-08-16

2. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes;Frontiers in Immunology;2024-08-01

3. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

4. Effect of statin use on liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease (NAFLD);Journal of Clinical Lipidology;2024-07

5. Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study;Nutrients;2024-04-20